Stock listing
NASDAQ:IOVA Iovance Biotherapeutics, Inc. Stock
Home listing (NASDAQ) of Iovance Biotherapeutics, Inc.
Follow Iovance Biotherapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IOVA
$14.21 USD +0.59 (+4.3%)
Close on Oct 19, 2026
- Day range
- $13.80 – $14.74 USDOct 19, 2026
- Volume
- 8.50M sharesOct 19, 2026
- Market cap
- $6.44B USDAt the close on Oct 19, 2026 · price × 453.0M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IOVA · Home | $14.21 USD | +0.59 (+4.3%) | 8,501,380 | $13.80 | $14.74 | $13.80 | $13.62 | Close on Oct 19, 2026 |
| Frankfurt:2LB | €12.12 EUR | -0.20 (-1.6%) | 868 | €12.12 | €12.12 | €12.12 | €12.32 | Close on Oct 19, 2026 |
| LSE:0JDK | $14.08 USD | +0.25 (+1.8%) | 81,381 | $13.75 | $14.74 | $13.52 | $13.83 | Close on Oct 19, 2026 |
| Stuttgart:2LB | €12.64 EUR | +0.56 (+4.6%) | 2,892 | €12.18 | €12.78 | €12.12 | €12.08 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:IOVA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $14.21 | +0.59 | +4.3% | $13.80 | $14.74 | $13.80 | 8,501,380 | |
| $13.62 | -1.10 | -7.5% | $14.65 | $14.69 | $13.52 | 12,155,046 | |
| $14.72 | +0.51 | +3.6% | $13.98 | $14.74 | $13.80 | 11,494,010 | |
| $14.21 | -0.29 | -2.0% | $14.35 | $14.64 | $14.15 | 10,596,800 | |
| $14.50 | -0.06 | -0.4% | $14.48 | $14.80 | $14.31 | 11,838,333 | |
| $14.56 | -0.06 | -0.4% | $14.50 | $14.82 | $14.20 | 9,108,900 | |
| $14.62 | +1.31 | +9.8% | $13.36 | $14.94 | $13.29 | 16,990,300 | |
| $13.31 | +0.39 | +3.0% | $12.65 | $13.40 | $12.62 | 14,824,100 | |
| $12.92 | -0.04 | -0.3% | $12.52 | $13.15 | $12.31 | 14,524,100 | |
| $12.96 | -1.19 | -8.4% | $14.21 | $14.21 | $12.92 | 18,953,900 | |
| $14.15 | -0.07 | -0.5% | $14.03 | $14.41 | $13.71 | 11,751,500 | |
| $14.22 | -0.01 | -0.1% | $14.45 | $14.75 | $13.95 | 11,914,800 | |
| $14.23 | -0.59 | -4.0% | $14.76 | $15.03 | $14.19 | 15,967,900 | |
| $14.82 | +0.37 | +2.6% | $14.65 | $15.11 | $14.10 | 29,341,700 | |
| $14.45 | +3.46 | +31.5% | $12.79 | $15.30 | $12.78 | 78,165,800 | |
| $10.99 | -0.01 | -0.1% | $10.88 | $11.17 | $10.68 | 12,233,200 | |
| $11.00 | +0.20 | +1.9% | $10.90 | $11.13 | $10.69 | 12,633,900 | |
| $10.80 | +0.61 | +6.0% | $10.40 | $10.83 | $10.15 | 11,926,900 | |
| $10.19 | -0.45 | -4.2% | $10.69 | $10.85 | $10.12 | 15,913,000 | |
| $10.64 | +0.45 | +4.4% | $10.18 | $10.80 | $10.03 | 16,058,200 | |
| $10.19 | -0.06 | -0.6% | $10.43 | $10.64 | $10.03 | 13,129,500 | |
| $10.25 | +0.23 | +2.3% | $10.12 | $10.27 | $9.83 | 22,879,700 | |
| $10.02 | +0.15 | +1.5% | $10.25 | $10.98 | $9.99 | 24,203,800 | |
| $9.87 | +0.51 | +5.4% | $9.45 | $9.93 | $9.44 | 19,693,900 | |
| $9.36 | +0.10 | +1.1% | $9.21 | $9.38 | $8.98 | 11,092,000 | |
| $9.26 | +0.66 | +7.7% | $8.56 | $9.41 | $8.54 | 21,033,600 | |
| $8.60 | +0.46 | +5.7% | $8.25 | $8.70 | $8.08 | 12,381,600 | |
| $8.14 | -0.29 | -3.4% | $8.32 | $8.42 | $8.04 | 10,565,100 | |
| $8.43 | -0.27 | -3.1% | $8.66 | $8.73 | $8.32 | 11,931,300 | |
| $8.70 | -0.09 | -1.0% | $8.69 | $8.91 | $8.48 | 9,535,300 | |
| $8.79 | +0.09 | +1.0% | $8.74 | $8.90 | $8.64 | 8,079,600 | |
| $8.70 | +0.08 | +0.9% | $8.65 | $8.79 | $8.55 | 14,637,200 | |
| $8.62 | +0.34 | +4.1% | $8.31 | $8.69 | $8.30 | 12,393,200 | |
| $8.28 | +0.11 | +1.3% | $8.02 | $8.29 | $7.97 | 6,754,300 | |
| $8.17 | +0.16 | +2.0% | $7.95 | $8.17 | $7.66 | 12,123,400 | |
| $8.01 | -0.25 | -3.0% | $8.20 | $8.35 | $7.97 | 7,693,500 | |
| $8.26 | +0.18 | +2.2% | $8.08 | $8.32 | $7.95 | 7,435,700 | |
| $8.08 | -0.36 | -4.3% | $8.34 | $8.55 | $8.02 | 10,102,300 | |
| $8.44 | +0.38 | +4.7% | $8.16 | $8.48 | $8.03 | 11,898,400 | |
| $8.06 | -0.23 | -2.8% | $8.08 | $8.36 | $7.79 | 15,731,200 | |
| $8.29 | -0.70 | -7.8% | $9.08 | $9.30 | $8.15 | 27,808,900 | |
| $8.99 | +1.00 | +12.5% | $8.07 | $9.36 | $7.96 | 43,812,300 | |
| $7.99 | +0.96 | +13.7% | $7.20 | $8.06 | $7.19 | 24,248,300 | |
| $7.03 | -0.07 | -1.0% | $7.00 | $7.31 | $6.93 | 10,499,400 | |
| $7.10 | +0.12 | +1.7% | $6.84 | $7.25 | $6.70 | 14,811,100 | |
| $6.98 | +0.46 | +7.1% | $6.52 | $7.00 | $6.36 | 17,507,600 | |
| $6.52 | -0.22 | -3.3% | $6.74 | $6.81 | $6.42 | 15,679,400 | |
| $6.74 | +0.25 | +3.9% | $6.49 | $6.74 | $6.39 | 13,458,700 | |
| $6.49 | +0.09 | +1.4% | $6.48 | $6.53 | $6.18 | 10,381,000 | |
| $6.40 | +0.06 | +0.9% | $6.31 | $6.61 | $6.16 | 17,306,200 | |
| $6.34 | +0.13 | +2.1% | $6.57 | $6.92 | $5.88 | 30,970,700 | |
| $6.21 | +1.87 | +43.1% | $5.95 | $6.39 | $5.63 | 73,430,600 | |
| $4.34 | -0.02 | -0.5% | $4.45 | $4.55 | $4.29 | 15,595,200 | |
| $4.36 | +0.04 | +0.9% | $4.39 | $4.48 | $4.29 | 10,682,100 | |
| $4.32 | +0.25 | +6.1% | $4.10 | $4.36 | $3.96 | 13,022,200 | |
| $4.07 | -0.62 | -13.2% | $4.43 | $4.55 | $4.02 | 19,974,500 | |
| $4.69 | +0.13 | +2.9% | $4.53 | $4.84 | $4.51 | 14,156,400 | |
| $4.56 | -0.14 | -3.0% | $4.73 | $4.78 | $4.50 | 10,785,700 | |
| $4.70 | -0.20 | -4.1% | $4.98 | $4.98 | $4.64 | 13,434,500 | |
| $4.90 | -0.09 | -1.8% | $5.02 | $5.16 | $4.86 | 13,245,300 | |
| $4.99 | -0.14 | -2.7% | $5.13 | $5.15 | $4.95 | 9,431,100 | |
| $5.13 | -0.04 | -0.8% | $5.03 | $5.28 | $5.00 | 9,732,100 | |
| $5.17 | -0.31 | -5.7% | $5.50 | $5.64 | $5.10 | 14,161,000 | |
| $5.48 | +0.46 | +9.2% | $5.07 | $5.53 | $5.02 | 20,354,200 | |
| $5.02 | +0.02 | +0.4% | $5.03 | $5.13 | $4.80 | 16,361,500 |
- Ticker
- NASDAQ:IOVA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
Latest earnings call · Aug 6, 2026
Iovance Biotherapeutics (NASDAQ:IOVA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 5, 2026
Investor Presentation (October 2026)
Investor deck · 34 slides
Calls
Replays
Iovance Biotherapeutics (NASDAQ:IOVA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:30 AM ET
Watch TranscriptIovance Biotherapeutics (NASDAQ:IOVA) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptIovance Biotherapeutics (NASDAQ:IOVA) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
Oct 19, 2026
Closed $14.21 (+4.3%) on Oct 19, 2026
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Oct 16, 2026
Closed $14.21 (+4.3%) on Oct 19, 2026
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Oct 1, 2026
Closed $14.23 (-4.0%) on Oct 1, 2026
Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
Sep 29, 2026
Closed $14.45 (+31.5%) on Sep 29, 2026
Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
Jul 30, 2026
Closed $4.69 (+2.9%) on Jul 30, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 34 slides · Oct 5, 2026
Investor Presentation (August 2026)
Investor deck · 34 slides · Aug 6, 2026
Investor Presentation (July 2026)
Investor deck · 32 slides · Jul 2, 2026
Investor Presentation (February 2026)
Investor deck · 33 slides · Feb 24, 2026
Iovance Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 106 in all · newest Oct 19, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 44 decks · latest Oct 5, 2026
Where Iovance Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IOVA · Home listing · This page | NASDAQ | United States | USD |
| gettex:2LB | gettex | Germany | EUR |
| LS Exchange:A2DT49 | LS Exchange | Germany | EUR |
| Tradegate:2LB | Tradegate | Germany | EUR |
| Frankfurt:2LB | Frankfurt | Germany | EUR |
| BOATS:IOVA | BOATS | United States | USD |
| Lang & Schwarz:A2DT49 | Lang & Schwarz | Germany | EUR |
| BX Swiss:IOVA | BX Swiss | Switzerland | CHF |
| Dusseldorf:2LB | Dusseldorf | Germany | EUR |
| LSE:0JDK | LSE | United Kingdom | USD |
| Milan:1IOVA | Milan | Italy | EUR |
| Stuttgart:2LB | Stuttgart | Germany | EUR |
| Hamburg:2LB | Hamburg | Germany | EUR |
| Munich:2LB | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Iovance Biotherapeutics, Inc.